Oppenheimer Downgrades Arcosa to Perform
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 26 2026
0mins
Oppenheimer downgraded Arcosa to Perform from Outperform without a price target after the company agreed to be acquired by CRH in an all-cash transaction for $150 per share.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ACA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ACA
Wall Street analysts forecast ACA stock price to fall
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 145.380
Low
115.00
Averages
115.00
High
115.00
Current: 145.380
Low
115.00
Averages
115.00
High
115.00
About ACA
Arcosa, Inc. is a provider of infrastructure-related products and solutions. The Company’s two principal business segments include Construction Products and Engineered Structures. The Construction Products segment primarily produces and sells natural and recycled aggregates, specialty materials, asphalt mix, and construction site support equipment, including trench shields and shoring products. It also produces recycled aggregates in the U.S. with operations in Texas, New Jersey, California, Florida, and Arizona. The Engineered Structures segment primarily manufactures and sells steel and concrete structures for infrastructure businesses, including utility structures for electricity transmission and distribution, structural wind towers, traffic and lighting structures, and telecommunication structures. These products share similar manufacturing competencies and steel sourcing requirements and can be manufactured across our North American footprint.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies such as Arcosa, Inc., Bio-Techne Corporation, Iridium Communications Inc., and LCI Industries for potential violations of federal securities laws and fiduciary duties to shareholders, including Arcosa's sale to CRH for $150 per share.
- Shareholder Rights: The firm encourages shareholders to contact them to discuss their rights and options at no cost, indicating a commitment to protecting investor interests and potentially seeking increased consideration or other remedies.
- Potential Impact: The terms of these transactions may limit superior competing offers, negatively affecting the financial interests of shareholders, particularly ordinary shareholders who may miss out on financial benefits available to insiders.
- Legal Service Model: Halper Sadeh LLC operates on a contingency fee basis, meaning shareholders do not incur out-of-pocket legal fees or expenses, thereby lowering the barrier for shareholders seeking legal assistance.
See More
Multiple Companies Under Investigation for Merger Deal Fairness
- LCI Merger Investigation: LCI Industries is set to be acquired by Patrick Industries in an all-stock deal where LCI shareholders will receive 1.2440 shares of Patrick for each LCI share, raising concerns about whether the LCI Board breached its fiduciary duties by failing to ensure fair pricing, potentially impacting shareholder value.
- Iridium Acquisition Scrutiny: Iridium Communications will be acquired by Rocket Lab for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8 billion, with investigations questioning whether the Iridium Board adequately protected shareholder interests during the deal process, risking fair value for shareholders.
- Bio-Techne Merger Review: Bio-Techne Corporation is to be acquired by Merck KGaA for $73 per share in cash, totaling an enterprise value of around $11.3 billion, with investigations focusing on whether the Bio-Techne Board conducted a fair process, potentially affecting shareholder returns.
- Arcosa Merger Investigation: Arcosa will be acquired by CRH for $150 per share in cash, with an enterprise value of approximately $8.5 billion, raising questions about whether the Arcosa Board fulfilled its fiduciary duties to shareholders, possibly leading to inadequate valuation in the transaction.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating Arcosa, Inc., Simulations Plus, Inc., AstroNova, Inc., and Fathom Holdings Inc. for potential violations of federal securities laws and fiduciary duties to shareholders, with transaction prices at $150.00, $18.50, $29.00, and 0.2236 shares of Bed Bath & Beyond stock respectively.
- Shareholder Rights Protection: The law firm encourages shareholders to contact them to discuss their rights and options, committing to handle matters on a contingent fee basis, which underscores their focus on safeguarding shareholder interests.
- Potential Financial Benefits: The investigation highlights that insiders may receive substantial financial benefits not available to ordinary shareholders, which could impact the fairness and transparency of the transactions, raising concerns among shareholders regarding the terms of the deals.
- Possibility of Legal Action: Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief measures to protect shareholders' rights, indicating their proactive involvement in addressing securities fraud and corporate misconduct.
See More
Ademi LLP Investigates Arcosa's Transaction Compliance
- Shareholder Rights Investigation: Ademi LLP is investigating Arcosa (NYSE: ACA) for potential breaches of fiduciary duty and other legal violations in its transaction with CRH, which may impact shareholder rights.
- Transaction Value and Structure: The all-cash deal values Arcosa at approximately $8.5 billion, with shareholders receiving $150 per share, indicating a high return but raising concerns about the board's conduct.
- Limitation on Competing Bids: The transaction agreement imposes significant penalties on Arcosa for accepting competing bids, potentially harming shareholder interests and prompting scrutiny of the board's actions.
- Board Responsibility Review: We are assessing whether Arcosa's board has fulfilled its fiduciary duties to all shareholders, ensuring that their decisions align with long-term shareholder interests and avoiding potential legal liabilities.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating Iridium Communications Inc. (NASDAQ: IRDM) regarding its sale to Rocket Lab Corporation for $27.00 per share in cash and stock, potentially infringing on shareholder rights.
- Bio-Techne Transaction: Bio-Techne Corporation (NASDAQ: TECH) is set to be sold to Merck KGaA for $73.00 per share in cash, with Halper Sadeh LLC possibly seeking increased consideration and additional disclosures to protect shareholder interests.
- SUNation Merger: The merger of SUNation Energy, Inc. (NASDAQ: SUNE) with Suniva is expected to result in SUNation shareholders owning approximately 1.8% of the combined entity, prompting Halper Sadeh LLC to assess the fairness of this transaction.
- Arcosa Sale: Arcosa, Inc. (NYSE: ACA) is proposed to be sold to CRH for $150.00 per share, with Halper Sadeh LLC potentially representing shareholders in seeking a higher purchase price and more disclosure information.
See More
Investigation Alerts for Multiple Company Mergers
- LCI Merger Investigation: LCI Industries is set to be acquired by Patrick Industries in an all-stock deal where shareholders will receive 1.2440 shares of Patrick for each LCI share, with investigations questioning whether the LCI Board breached fiduciary duties by failing to ensure a fair process.
- Iridium Acquisition Details: Iridium Communications will be acquired by Rocket Lab for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8 billion, with investigations focusing on whether the Iridium Board adequately protected shareholder interests during the process.
- Bio-Techne Merger Review: Bio-Techne Corporation is to be acquired by Merck KGaA for $73 per share in cash, totaling an enterprise value of about $11.3 billion, with investigations examining whether the Bio-Techne Board conducted a fair process to ensure shareholders receive fair value.
- Arcosa Acquisition Inquiry: Arcosa will be acquired by CRH for $150 per share in cash, with an enterprise value of approximately $8.5 billion, and investigations questioning whether the Arcosa Board fulfilled its fiduciary duties to ensure fair value for shareholders.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating companies such as Arcosa, Inc., Bio-Techne Corporation, Iridium Communications Inc., and LCI Industries for potential violations of federal securities laws and fiduciary duties to shareholders, including Arcosa's sale to CRH for $150 per share.
- Shareholder Rights: The firm encourages shareholders to contact them to discuss their rights and options at no cost, indicating a commitment to protecting investor interests and potentially seeking increased consideration or other remedies.
- Potential Impact: The terms of these transactions may limit superior competing offers, negatively affecting the financial interests of shareholders, particularly ordinary shareholders who may miss out on financial benefits available to insiders.
- Legal Service Model: Halper Sadeh LLC operates on a contingency fee basis, meaning shareholders do not incur out-of-pocket legal fees or expenses, thereby lowering the barrier for shareholders seeking legal assistance.
See More
Multiple Companies Under Investigation for Merger Deal Fairness
- LCI Merger Investigation: LCI Industries is set to be acquired by Patrick Industries in an all-stock deal where LCI shareholders will receive 1.2440 shares of Patrick for each LCI share, raising concerns about whether the LCI Board breached its fiduciary duties by failing to ensure fair pricing, potentially impacting shareholder value.
- Iridium Acquisition Scrutiny: Iridium Communications will be acquired by Rocket Lab for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8 billion, with investigations questioning whether the Iridium Board adequately protected shareholder interests during the deal process, risking fair value for shareholders.
- Bio-Techne Merger Review: Bio-Techne Corporation is to be acquired by Merck KGaA for $73 per share in cash, totaling an enterprise value of around $11.3 billion, with investigations focusing on whether the Bio-Techne Board conducted a fair process, potentially affecting shareholder returns.
- Arcosa Merger Investigation: Arcosa will be acquired by CRH for $150 per share in cash, with an enterprise value of approximately $8.5 billion, raising questions about whether the Arcosa Board fulfilled its fiduciary duties to shareholders, possibly leading to inadequate valuation in the transaction.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating Arcosa, Inc., Simulations Plus, Inc., AstroNova, Inc., and Fathom Holdings Inc. for potential violations of federal securities laws and fiduciary duties to shareholders, with transaction prices at $150.00, $18.50, $29.00, and 0.2236 shares of Bed Bath & Beyond stock respectively.
- Shareholder Rights Protection: The law firm encourages shareholders to contact them to discuss their rights and options, committing to handle matters on a contingent fee basis, which underscores their focus on safeguarding shareholder interests.
- Potential Financial Benefits: The investigation highlights that insiders may receive substantial financial benefits not available to ordinary shareholders, which could impact the fairness and transparency of the transactions, raising concerns among shareholders regarding the terms of the deals.
- Possibility of Legal Action: Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief measures to protect shareholders' rights, indicating their proactive involvement in addressing securities fraud and corporate misconduct.
See More
Ademi LLP Investigates Arcosa's Transaction Compliance
- Shareholder Rights Investigation: Ademi LLP is investigating Arcosa (NYSE: ACA) for potential breaches of fiduciary duty and other legal violations in its transaction with CRH, which may impact shareholder rights.
- Transaction Value and Structure: The all-cash deal values Arcosa at approximately $8.5 billion, with shareholders receiving $150 per share, indicating a high return but raising concerns about the board's conduct.
- Limitation on Competing Bids: The transaction agreement imposes significant penalties on Arcosa for accepting competing bids, potentially harming shareholder interests and prompting scrutiny of the board's actions.
- Board Responsibility Review: We are assessing whether Arcosa's board has fulfilled its fiduciary duties to all shareholders, ensuring that their decisions align with long-term shareholder interests and avoiding potential legal liabilities.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating Iridium Communications Inc. (NASDAQ: IRDM) regarding its sale to Rocket Lab Corporation for $27.00 per share in cash and stock, potentially infringing on shareholder rights.
- Bio-Techne Transaction: Bio-Techne Corporation (NASDAQ: TECH) is set to be sold to Merck KGaA for $73.00 per share in cash, with Halper Sadeh LLC possibly seeking increased consideration and additional disclosures to protect shareholder interests.
- SUNation Merger: The merger of SUNation Energy, Inc. (NASDAQ: SUNE) with Suniva is expected to result in SUNation shareholders owning approximately 1.8% of the combined entity, prompting Halper Sadeh LLC to assess the fairness of this transaction.
- Arcosa Sale: Arcosa, Inc. (NYSE: ACA) is proposed to be sold to CRH for $150.00 per share, with Halper Sadeh LLC potentially representing shareholders in seeking a higher purchase price and more disclosure information.
See More
Investigation Alerts for Multiple Company Mergers
- LCI Merger Investigation: LCI Industries is set to be acquired by Patrick Industries in an all-stock deal where shareholders will receive 1.2440 shares of Patrick for each LCI share, with investigations questioning whether the LCI Board breached fiduciary duties by failing to ensure a fair process.
- Iridium Acquisition Details: Iridium Communications will be acquired by Rocket Lab for $54 per share in a cash and stock transaction, representing an enterprise value of approximately $8 billion, with investigations focusing on whether the Iridium Board adequately protected shareholder interests during the process.
- Bio-Techne Merger Review: Bio-Techne Corporation is to be acquired by Merck KGaA for $73 per share in cash, totaling an enterprise value of about $11.3 billion, with investigations examining whether the Bio-Techne Board conducted a fair process to ensure shareholders receive fair value.
- Arcosa Acquisition Inquiry: Arcosa will be acquired by CRH for $150 per share in cash, with an enterprise value of approximately $8.5 billion, and investigations questioning whether the Arcosa Board fulfilled its fiduciary duties to ensure fair value for shareholders.
See More
